(Reuters) -Amgen will test its obesity drug candidate in patients at risk of weight-related conditions such as heart, liver and kidney diseases in its late-stage trial, the company's CEO Robert ...

The novel metabolic predictor emphasizes central adiposity, while integrating metabolites and other measures of metabolic ...

Add Yahoo as a preferred source to see more of our stories on Google. More than 2 out of 5 adults in the U.S. are considered obese, according to the Centers for Disease Control and Prevention. But ...

The future is uncertain — but your kid’s waistline as an adult might not be. Scientists have developed a groundbreaking test that can identify children as young as five who are at increased risk of ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

A genetic test may one day predict a child’s risk of obesity in adulthood, paving the way for early interventions. Certain genetic variants can affect how a person’s body stores fat or make them more ...

What if we could prevent people from developing obesity? The World Obesity Federation expects more than half the global population to develop overweight or obesity by 2035. However, treatment ...

Scientists may have found a new way to spot early signs of obesity, which could lead to novel prevention strategies. A study ...